ROR2 and cancer: While the lack of the first, Ig-like extracellular domain, did not affect the invasion-promoting effect of ROR2, a trend (p = 0.08) for reduced cancer cell invasiveness was observed when overexpressing ROR2 lacking the CRD (Fig. 3h).